Delivery Order SPE2DB22D1106-SPE2DB25FEUN5

Award Date 6/23/25
Potential Completion Date 6/24/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,492.62 contract is for the supply of ALVIMOPAN 12 MG CAPSULE UD 30S, a medication. The contract has an ultimate completion date of June 20, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $19,230.24, is for the delivery of 4563968997 - ALVIMOPAN 12 MG CAPSULE UD 30S, a pharmaceutical product, with a completion date of March 15, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves...
This is a $24,354.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ALVIMOPAN 12 MG CAPSULE UD 30S, a medical product, and has an ultimate completion date of December 31, 2024. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger $999,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,601,268 units of the pharmaceutical product Alvimopan 12 mg capsules. The total ceiling value of the contract is $47,144.31, with a performance period extending to June 23, 2025. The contract is not set aside and was awarded on an open competition basis....
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, to provide ALVIMOPAN 12 MG CAPSULE UD 30S. The contract has a potential value of $4,937.71 and a completion date of January 30, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,080.46 firm fixed-price delivery order is for the provision of 4,564,898,629 units of the prescription medication Alvimopan 12 mg capsules. The award does not include a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price and a ceiling value of $122,911.46, with a completion date of June 17, 2025. The contract is not set-aside and involves the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs, including medications across multiple...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,508.13 and a performance period through May 2025. It is a firm fixed-price contract for the delivery of various pharmaceutical and medical products, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $260,752.01 and is a firm fixed-price delivery order, with an ultimate completion date of May 15, 2025. The contract provides for the delivery of a range of pharmaceutical products and medical supplies, including medications across various therapeutic areas such as...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a total ceiling value of $32,936.04 and an ultimate completion date of June 13, 2025. The contract is not set-aside and provides for the delivery of a variety of pharmaceutical products and medical supplies to support federal agencies, particularly the military and veteran healthcare systems. Amerisourcebergen Drug Corp...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEUN5
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568616987 - ALVIMOPAN 12 MG CAPSULE UD 30S, with a ceiling value of $16,222.90. The contract is a firm fixed-price delivery order, with a performance period ending on June 24, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order is a part of that larger IDC contract, allowing the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

The contract is not designated as a set-aside.

Generated 9/28/25, 1:55 AM